Taking Weekends Off Dasatinib Maintains Responses in First-Line CML

The phase 3 DasaHIT trial found that weekend dasatinib breaks maintained CML responses in first-line patients, with fewer effusions in exploratory analyses.

The phase 3 DasaHIT trial found that weekend dasatinib breaks maintained CML responses in first-line patients, with fewer effusions in exploratory analyses.